Edesa Biotech Inc (EDSA) — Cash Flow-to-Debt Ratio
Edesa Biotech Inc (EDSA) has a Cash Flow-to-Debt Ratio of -1.46x as of September 2025, meaning its operating cash flow of $-1.77 Million could theoretically repay -1% of its total liabilities ($1.21 Million) in one year. See Edesa Biotech Inc (EDSA) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Edesa Biotech Inc Cash Flow-to-Debt Ratio (2010–2025)
Historical debt coverage capacity for Edesa Biotech Inc across 16 annual periods. Also explore Edesa Biotech Inc (EDSA) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Edesa Biotech Inc (2010–2025)
Year-by-year debt coverage analysis for Edesa Biotech Inc. For market capitalisation and broader financial context, see EDSA market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -6.05x | $-7.32 Million | $1.21 Million | ▼ -126.9% |
| 2024 | -2.67x | $-4.89 Million | $1.83 Million | ▲ +26.0% |
| 2023 | -3.60x | $-6.64 Million | $1.84 Million | ▲ +35.9% |
| 2022 | -5.62x | $-12.28 Million | $2.18 Million | ▲ +37.2% |
| 2021 | -8.95x | $-13.66 Million | $1.53 Million | ▼ -641.7% |
| 2020 | -1.21x | $-4.99 Million | $4.13 Million | ▲ +88.5% |
| 2019 | -10.50x | $-4.85 Million | $461.63K | ▼ -12.2% |
| 2018 | -9.35x | $-4.62 Million | $493.38K | ▲ +36.1% |
| 2017 | -14.64x | $-4.70 Million | $320.95K | ▼ -102.7% |
| 2016 | -7.22x | $-4.51 Million | $623.64K | ▼ -289.8% |
| 2015 | -1.85x | $-4.41 Million | $2.38 Million | ▼ -194.2% |
| 2014 | -0.63x | $-4.27 Million | $6.77 Million | ▼ -151.0% |
| 2013 | -0.25x | $-2.92 Million | $11.65 Million | ▲ +95.6% |
| 2012 | -5.70x | $-3.95 Million | $692.27K | ▲ +65.3% |
| 2011 | -16.44x | $-2.62 Million | $159.14K | ▼ -844.5% |
| 2010 | -1.74x | $-732.23K | $420.61K | — |